| Line Item | 2024-02-04 | Y/Y |
|---|---|---|
| Revenue | $2.83B | +2.8% |
| Cost of Revenue | $809.4M | -5.4% |
| Gross Profit | $2.02B | +6.5% |
| R&D Expense | $736.8M | +6.4% |
| SG&A Expense | $252.2M | +6.0% |
| Operating Income | $53.6M | -35.9% |
| Interest Expense | $7.5M | +57.6% |
| Pre-tax Income | $90.6M | -1.3% |
| Income Tax | $29.3M |
| Line Item | 2024-02-04 | Y/Y |
|---|---|---|
| Cash & Equivalents | $702.5M | +20.9% |
| Accounts Receivable | $662.2M | +8.1% |
| Inventory | $42.7M | -14.9% |
| Current Assets | $2.50B | +0.9% |
| Total Assets | $3.66B | +3.2% |
| Current Liabilities | $1.37B | -22.0% |
| Long-term Debt | $100.0M | — |
| Line Item | 2024-02-04 | Y/Y |
|---|---|---|
| Operating Cash Flow | $677.7M | -11.7% |
| Capital Expenditures | $195.2M | +23.4% |
| Investing Cash Flow | $3.2M | +101.5% |
| Financing Cash Flow | -$560.2M | -29.9% |
| Free Cash Flow | $482.6M | -20.8% |
| +56.2% |
| Net Income | $61.3M | -16.1% |
| EPS (Basic) | $0.20 | -16.7% |
| EPS (Diluted) | $0.19 | -17.4% |
| Total Liabilities |
| $2.39B |
| -8.3% |
| Stockholders' Equity | $1.27B | +34.9% |